Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

Presentation THT 2025

Impact of Age on Clinical Outcomes Following HeartMate 3 LVAD Implantation: Insights From the MOMENTUM 3 Trial

Presenter: Nir Uriel

February 12, 2025

Presentation THT 2025

Incidence and Outcome of Early and Late Right Ventricular Failure in Patients with the HeartMate 3 LVAD: A MOMENTUM 3 Analysis

Presenter: Gabriel Sayer

February 11, 2025

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Daily News

HeartMate 3 Use Postapproval Is Soaring—and Equitably, New Numbers Show

Yael L. Maxwell

January 10, 2024

Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HCM3

News Conference News AHA 2023

Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HM3

Shelley Wood

November 11, 2023

News Daily News

Many Young Patients With AR Do Not Achieve LV Normalization With Surgery

L.A. McKeown

September 26, 2023

Presentation THT 2023

HeartMate 3 LVAD beyond MOMENTUM 3 – Where are we now?

Presenter: Scott Silvestry

March 21, 2023

News Conference News THT 2023

TEER or VAD/Transplant in the Advanced HF Patient With MR?

Shelley Wood

March 20, 2023

News Daily News

STRONG-HF: Fast Optimal GDMT Cuts Deaths, Hospitalizations in Acute HF

Shelley Wood

October 17, 2022

News Conference News HFSA 2022

No Benefit of LAA Ligation During HeartMate 3 Implantation: MOMENTUM 3

Yael L. Maxwell

October 07, 2022

News Daily News

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

Michael O'Riordan

September 09, 2022

News Features

A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial Shunts

Shelley Wood

July 07, 2022

News Daily News

Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF

L.A. McKeown

December 07, 2021

News Features

Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses

Shelley Wood

December 23, 2019

News Conference News ACC 2019

Final MOMENTUM 3 Results Secure Superiority Claim for HeartMate 3 LVAD

Shelley Wood

March 22, 2019

News Daily News

FDA Approves HeartMate 3 as Destination Therapy in Advanced HF

Michael O'Riordan

October 19, 2018

News Conference News ACC 2018

Newest HeartMate 3 LV Assist Device Slashes Thrombosis, Reoperation Rates in Advanced HF: MOMENTUM 3

Shelley Wood

March 16, 2018

Presentation TCT 2017

ENDURANCE of MOMENTUM: Destination Therapy State-of-the-Art

Presenter: Ulrich P. Jorde

November 01, 2017

News Conference News AHA 2016

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Shelley Wood

November 09, 2016

News Industry News

Blue Light Sets The Beat In Biological Pacemaker

June 22, 2015

Advertisement

Impact of Age on Clinical Outcomes Following HeartMate 3 LVAD Implantation: Insights From the MOMENTUM 3 Trial

Incidence and Outcome of Early and Late Right Ventricular Failure in Patients with the HeartMate 3 LVAD: A MOMENTUM 3 Analysis

November 2024 Dispatch for the CV Team

HeartMate 3 Use Postapproval Is Soaring—and Equitably, New Numbers Show

Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HM3

Many Young Patients With AR Do Not Achieve LV Normalization With Surgery

HeartMate 3 LVAD beyond MOMENTUM 3 – Where are we now?

TEER or VAD/Transplant in the Advanced HF Patient With MR?

STRONG-HF: Fast Optimal GDMT Cuts Deaths, Hospitalizations in Acute HF

No Benefit of LAA Ligation During HeartMate 3 Implantation: MOMENTUM 3

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial Shunts

Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF

Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses

Final MOMENTUM 3 Results Secure Superiority Claim for HeartMate 3 LVAD

FDA Approves HeartMate 3 as Destination Therapy in Advanced HF

Newest HeartMate 3 LV Assist Device Slashes Thrombosis, Reoperation Rates in Advanced HF: MOMENTUM 3

ENDURANCE of MOMENTUM: Destination Therapy State-of-the-Art

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Blue Light Sets The Beat In Biological Pacemaker

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content